Therefore, to diagnose the IPT variant of FDCS correctly, we must perform extensive immunohistochemical staining and recognize real tumor cells as positive for EBV markers (EBER–ISH, CD21, CD23, or CD35) and negative for IgG4 and ALK. Here, FCER2 is linked to neoplasm.